JPH07500267A - 酵素−角膜矯正法 - Google Patents

酵素−角膜矯正法

Info

Publication number
JPH07500267A
JPH07500267A JP5507793A JP50779393A JPH07500267A JP H07500267 A JPH07500267 A JP H07500267A JP 5507793 A JP5507793 A JP 5507793A JP 50779393 A JP50779393 A JP 50779393A JP H07500267 A JPH07500267 A JP H07500267A
Authority
JP
Japan
Prior art keywords
cornea
contact lens
eye
corneal
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5507793A
Other languages
English (en)
Japanese (ja)
Inventor
ハリス　ドナルド　エイチ．
メイ　チャールズ
カラジョジアン　ハンパー
Original Assignee
イスタ　ファーマスーティカルズ　インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by イスタ　ファーマスーティカルズ　インコーポレイテッド filed Critical イスタ　ファーマスーティカルズ　インコーポレイテッド
Publication of JPH07500267A publication Critical patent/JPH07500267A/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041—Lenses
    • G02B1/043—Contact lenses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/013—Instruments for compensation of ocular refraction ; Instruments for use in cornea removal, for reshaping or performing incisions in the cornea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/30—Copper compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/305—Mercury compounds
    • A61K31/31—Mercury compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A61K31/708—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid having oxo groups directly attached to the purine ring system, e.g. guanosine, guanylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes
    • G02C7/047—Contact lens fitting; Contact lenses for orthokeratology; Contact lenses for specially shaped corneae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Eyeglasses (AREA)
  • Saccharide Compounds (AREA)
  • Prostheses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP5507793A 1991-10-15 1992-10-15 酵素−角膜矯正法 Pending JPH07500267A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US776,211 1991-10-15
US07/776,211 US5270051A (en) 1991-10-15 1991-10-15 Enzyme-orthokeratology
PCT/US1992/008791 WO1993007840A1 (en) 1991-10-15 1992-10-15 Enzyme-orthokeratology

Publications (1)

Publication Number Publication Date
JPH07500267A true JPH07500267A (ja) 1995-01-12

Family

ID=25106777

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5507793A Pending JPH07500267A (ja) 1991-10-15 1992-10-15 酵素−角膜矯正法

Country Status (14)

Country Link
US (2) US5270051A (cs)
EP (1) EP0608341B1 (cs)
JP (1) JPH07500267A (cs)
KR (2) KR100256038B1 (cs)
AT (1) ATE214904T1 (cs)
AU (1) AU668526B2 (cs)
BR (1) BR9206629A (cs)
CA (1) CA2120709C (cs)
CZ (1) CZ285542B6 (cs)
DE (1) DE69232515T2 (cs)
ES (1) ES2173870T3 (cs)
RU (1) RU2137449C1 (cs)
SG (1) SG48971A1 (cs)
WO (1) WO1993007840A1 (cs)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998010785A1 (fr) * 1996-09-13 1998-03-19 Advanced Medicine Research Institute Compositions ophtalmiques de facteurs neurotrophiques, remedes pour troubles fonctionnels du nerf optique et procede de traitement de tels troubles
JP2007514760A (ja) * 2003-12-19 2007-06-07 オシオ コーポレイション 眼科的状態の処置
WO2009090763A1 (ja) * 2008-01-16 2009-07-23 Tokuichiro Hasegawa 視力矯正冶具及び同冶具用の冷却流体注入具
JP2011516154A (ja) * 2008-04-04 2011-05-26 フォーサイト ラブズ， エルエルシー 疼痛管理および視力のための治療装置
JP2011167992A (ja) * 2010-02-21 2011-09-01 Seed Co Ltd 環状医療具の成形型及びこの成形型を用いて成形された環状医療具
JP2013078659A (ja) * 2003-12-19 2013-05-02 Osio Corp 眼科的状態の処置
JP2015036080A (ja) * 2013-08-14 2015-02-23 石根 三井 矯正角膜クロスリンキング用コンタクトレンズ及び矯正角膜のクロスリンキング方法
JP2015508319A (ja) * 2012-01-27 2015-03-19 エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ （ウ・ペ・エフ・エル）Ｅｃｏｌｅ Ｐｏｌｙｔｅｃｈｎｉｑｕｅ Ｆｅｄｅｒａｌｅｄｅ Ｌａｕｓａｎｎｅ （Ｅｐｆｌ） 懸濁液中の細胞を移植するためのデバイス
WO2015076215A1 (ja) * 2013-11-20 2015-05-28 石根 三井 矯正角膜クロスリンキング用コンタクトレンズ、矯正角膜のクロスリンキング方法及びリング状コンタクトレンズ
US9086580B2 (en) 2012-08-10 2015-07-21 Osio Corporation Contact lens use in the treatment of an ophthalmologic condition
WO2016056575A1 (ja) * 2014-10-10 2016-04-14 石根 三井 矯正角膜クロスリンキング用コンタクトレンズ
JP2016081028A (ja) * 2014-10-10 2016-05-16 石根 三井 リング状角膜矯正用コンタクトレンズ
JP2016521377A (ja) * 2013-03-29 2016-07-21 ワンフォーカス テクノロジー， エルエルシー 流体モジュールを有するコンタクトレンズからの薬物送達
WO2017111027A1 (ja) * 2015-12-22 2017-06-29 石根 三井 矯正角膜クロスリンキング用コンタクトレンズ及びその製造方法
JP2018016646A (ja) * 2003-12-19 2018-02-01 オシオ コーポレイション 眼科的状態の処置
JP2019511493A (ja) * 2016-03-08 2019-04-25 ユニバーシティー オブ ユタ リサーチ ファウンデーションＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｕｔａｈ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 交差架橋剤、及び関連する方法
JP2022544020A (ja) * 2019-07-24 2022-10-17 テウォン ファーム カンパニー リミテッド コンタクトレンズ、及びそれを製造するためのモールド

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270051A (en) * 1991-10-15 1993-12-14 Harris Donald H Enzyme-orthokeratology
US5788957A (en) * 1991-10-15 1998-08-04 Advanced Corneal Systems, Inc. Enzyme-orthokeratology
US5518732A (en) * 1995-02-14 1996-05-21 Chiron Vision, Inc. Bio-erodible ophthalmic shield
US6610292B2 (en) 1995-11-22 2003-08-26 Ista Pharmaceuticals, Inc. Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
US5866120A (en) 1995-11-22 1999-02-02 Advanced Corneal Systems, Inc. Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase
PL185924B1 (pl) * 1996-03-15 2003-08-29 Scient Optics Soczewka kontaktowa i ortokeratologiczna soczewkaSoczewka kontaktowa i ortokeratologiczna soczewkakontaktowa, zwłaszcza do stosowania w przypadku okkontaktowa, zwłaszcza do stosowania w przypadku oka z asymetryczną, asferyczną rogówkąa z asymetryczną, asferyczną rogówką
US6010219A (en) * 1996-06-28 2000-01-04 Contex, Inc. Fenestrated contact lens for treating myopia
US5847803A (en) * 1996-09-17 1998-12-08 Innotech, Inc. Optic incorporating a power gradient
AU5805998A (en) * 1997-01-02 1998-07-31 Allergan Sales, Inc. Method for changing the refractive power of an eye
AU5312198A (en) * 1997-01-06 1998-08-03 Klaus Trier Aps Screening method
JPH10339857A (ja) * 1997-06-05 1998-12-22 Menicon Co Ltd 薬剤徐放性コンタクトレンズの製法およびそれによってえられた薬剤徐放性コンタクトレンズ
GB2333456A (en) * 1998-01-23 1999-07-28 Dowd Owen O Device for reshaping the cornea
US6161544A (en) * 1998-01-28 2000-12-19 Keratoform, Inc. Methods for accelerated orthokeratology
AU758862B2 (en) * 1998-03-09 2003-04-03 Ista Pharmaceuticals, Inc Use of corneal hardening agents in enzyme orthokeratology
US6335006B1 (en) 1999-03-22 2002-01-01 Boston Innovative Optics, Inc. Methods of using agents that act on the epithelial sheet of a human eye
PT1173198E (pt) * 1999-04-29 2004-04-30 Ista Pharmaceuticals Inc Utilizacao de uma determinada hialuronidase para eliminar as cicatrizes a opacificacao e a nevoa corneais
WO2000074648A2 (en) 1999-06-04 2000-12-14 Sunrise Technologies International, Inc. Prevention of regression in refractive keratoplasty
US6946440B1 (en) 1999-09-15 2005-09-20 Dewoolfson Bruce H Composition for stabilizing corneal tissue during or after orthokeratology lens wear
ES2338750T3 (es) * 1999-09-15 2010-05-12 Euclid Systems Corporation Composicion para la estabilizacion del tejido de la cornea durante o despues de llevar las lentillas de contacto de ortoqueratologia.
US6569661B1 (en) 1999-11-12 2003-05-27 Biomarin Pharmaceutical Inc. Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
US6426208B1 (en) * 1999-11-12 2002-07-30 Harbor-Ucla Research And Education Institute Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
US6585971B1 (en) 1999-11-12 2003-07-01 Harbor-Ucla Research And Education Institute Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof
US20030199574A1 (en) * 2000-03-02 2003-10-23 Vitreo-Retinal Technologies, Inc. Treatment of ophthalmic disorders using urea and urea derivatives
US7977385B2 (en) * 2000-03-02 2011-07-12 Numoda Biotechnologies, Inc. Agents for corneal or intrastromal administration to treat or prevent disorders of the eye
CN1177243C (zh) * 2000-06-27 2004-11-24 佳视科学公司 隐形眼镜，配制，设计及改变角膜形状的方法
US6902548B1 (en) * 2001-03-19 2005-06-07 Ed Schuler Use of Streptomyces hyalurolyticus enzyme in ophthalmic treatments
US20060040348A1 (en) * 2001-11-13 2006-02-23 Minmin Qin Methods for producing and purifying recombinant alpha-L-iduronidase
US20060177430A1 (en) * 2002-12-20 2006-08-10 Chakshu Research Inc Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
US20060172972A1 (en) * 2002-12-20 2006-08-03 Chakshu Research Inc Formulation and method for administration of ophthalmologically active agents
US20060166879A1 (en) * 2002-12-20 2006-07-27 Chakshu Research Inc Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
NZ540885A (en) * 2002-12-20 2009-02-28 Chakshu Res Inc Ophthalmic formulation for the prevention and treatment of ocular conditions
US6969514B2 (en) * 2003-02-05 2005-11-29 Soll David B Method for treating elevated intraocular pressure, including glaucoma
RU2257575C2 (ru) * 2003-03-31 2005-07-27 Кировская клиническая офтальмологическая больница Способ определения механической твёрдости хрусталика
US20050106270A1 (en) * 2003-10-06 2005-05-19 Devore Dale P. Chemical treatment of in vivo tissue to alter charge and net charge density characteristics
ES2322850T3 (es) * 2004-02-03 2009-06-30 Iroc Ag Dispositivo oftalmologico.
US7246902B2 (en) * 2004-02-25 2007-07-24 Paragon Vision Sciences, Inc. Corneal reshaping apparatus and method
US20050213031A1 (en) * 2004-02-25 2005-09-29 Meyers William E Method for determining corneal characteristics used in the design of a lens for corneal reshaping
US7680065B2 (en) * 2005-01-18 2010-03-16 Cisco Technology, Inc. System and method for routing information packets
RU2272599C1 (ru) * 2004-10-05 2006-03-27 Ирина Александровна Маклакова Биоматериал для стабилизации прогрессирующей миопии "коллаплант"
KR100599024B1 (ko) 2005-01-19 2006-07-12 범진선 관통공이 형성된 각막굴절교정용 콘택트 렌즈
RU2286170C1 (ru) * 2005-06-17 2006-10-27 Уфимский научно-исследовательский институт глазных болезней Глазная пленка
US20060290882A1 (en) * 2005-06-27 2006-12-28 Paragon Vision Sciences, Inc. Laminated contact lens
US20070021505A1 (en) * 2005-07-15 2007-01-25 Chakshu Research, Inc Prevention and treatment of ophthalmic complications of diabetes
US8801781B2 (en) * 2005-10-26 2014-08-12 Abbott Medical Optics Inc. Intraocular lens for correcting corneal coma
WO2008118938A1 (en) * 2007-03-26 2008-10-02 Theta Research Consultants, Llc Method and apparatus for ophthalmic medication delivery and ocular wound recovery
US8480638B2 (en) * 2007-10-04 2013-07-09 Aciont, Inc. Intraocular iontophoretic device and associated methods
US7985208B2 (en) * 2008-09-18 2011-07-26 Oasis Research LLC Ring shaped contoured collagen shield for ophthalmic drug delivery
US20100082018A1 (en) * 2008-09-26 2010-04-01 Daryus Panthakey Method and system for reshaping the cornea
EP2401648A4 (en) * 2009-02-27 2014-01-08 Euclid Systems Corp LENS PORT OF ORTHOKERATOLOGY COMBINED WITH CHEMICAL TREATMENT TO CORRECT MYOPIA, HYPERMETROPY OR ASTIGMATIA
US20120219554A2 (en) * 2009-05-14 2012-08-30 Fidia Farmaceutici S.P.A. Extracellular yaluronidase from streptomyces koganeiensis
EP3260092A1 (en) 2009-10-23 2017-12-27 Nexisvision, Inc. Corneal denervation for treatment of ocular pain
US8591025B1 (en) 2012-09-11 2013-11-26 Nexisvision, Inc. Eye covering and refractive correction methods for LASIK and other applications
WO2011050365A1 (en) 2009-10-23 2011-04-28 Forsight Labs, Llc Conformable therapeutic shield for vision and pain
US9256082B2 (en) 2010-03-18 2016-02-09 Vicoh, Llc Laminated composite lens
US8408698B2 (en) * 2010-03-18 2013-04-02 Vicoh, Llc Laminated composite lens
US10413506B2 (en) 2010-04-03 2019-09-17 Praful Doshi Medical devices including medicaments and methods of making and using same including enhancing comfort, enhancing drug penetration, and treatment of myopia
ES2634551T3 (es) 2010-04-03 2017-09-28 Praful Doshi Métodos para revestir una lente de contacto
US9395558B2 (en) 2010-10-25 2016-07-19 Nexisvision, Inc. Methods and apparatus to identify eye coverings for vision
US8864306B2 (en) 2011-04-28 2014-10-21 Nexisvision, Inc. Eye covering and refractive correction methods and apparatus having improved tear flow, comfort, and/or applicability
US12044905B2 (en) 2011-04-28 2024-07-23 Journey1 Inc Contact lenses for refractive correction
US9046699B2 (en) * 2012-03-13 2015-06-02 Johnson & Johnson Vision Care, Inc. Dynamic fluid zones in contact lenses
EP2841985A1 (en) 2012-04-20 2015-03-04 Nexisvision, Inc. Contact lenses for refractive correction
US9465233B2 (en) 2012-04-20 2016-10-11 Nexisvision, Inc. Bimodular contact lenses
EP2855132B1 (en) 2012-05-25 2019-10-16 Paragon CRT Company LLC Multicomponent optical device having a space
US10712588B2 (en) 2012-05-25 2020-07-14 Paragon Crt Company Llc Contact lens having a space
US10049275B2 (en) 2012-05-25 2018-08-14 Paragon Crt Company Llc Multicomponent optical device for visual and audible translation and recognition
US11079613B2 (en) * 2013-03-05 2021-08-03 EyeYon Medical Ltd. Contact lens drug depot
CA2916885A1 (en) 2013-06-26 2014-12-31 Nexisvision, Inc. Contact lenses for refractive correction
US9636050B1 (en) 2013-11-07 2017-05-02 Verily Life Sciences Llc Methods and apparatus for forming a channel through a polymer layer using a protrusion
US9341864B2 (en) 2013-11-15 2016-05-17 Nexisvision, Inc. Contact lenses having a reinforcing scaffold
WO2015116559A1 (en) 2014-01-29 2015-08-06 Nexisvision, Inc. Multifocal bimodulus contact lenses
US10232531B1 (en) 2014-07-08 2019-03-19 Verily Life Sciences Llc Methods and apparatus for forming a polymer layer around a structure using a plurality of protrusions
US9907498B2 (en) 2014-09-04 2018-03-06 Verily Life Sciences Llc Channel formation
WO2016076743A1 (ru) * 2014-11-13 2016-05-19 Аслан Рамазанович ХУРАЙ Контактная линза для коррекции зрения (варианты)
CN107249678B (zh) * 2014-12-19 2021-02-19 凯敏工业公司 使用离子电渗法进行生物活性分子的眼内递送
CN107632410A (zh) * 2016-07-19 2018-01-26 上海根植企业管理咨询有限公司 一种角膜塑形镜试戴片的组合方法
KR102077579B1 (ko) * 2019-08-14 2020-02-14 이정훈 각막굴절교정용 렌즈
KR20220100541A (ko) * 2021-01-08 2022-07-15 대원제약주식회사 약물전달용 콘택트렌즈 및 안과용 약학적 조성물

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1929228A (en) * 1931-05-14 1933-10-03 Benjamin L Wilhelm Contact eyeglass construction
DE861753C (de) * 1950-03-28 1953-01-05 Mueller Welt G M B H Augenhaftglas
US3302646A (en) * 1964-01-10 1967-02-07 Charles A Behney Apparatus for treating eye infection
US3416530A (en) * 1966-03-02 1968-12-17 Richard A. Ness Eyeball medication dispensing tablet
US3485244A (en) * 1966-12-15 1969-12-23 Hyman Rosen Eye applicator
US3710796A (en) * 1971-05-14 1973-01-16 C Neefe Corneal drug delivery method
US3786812A (en) * 1972-03-10 1974-01-22 C Neefe Contact lens for olar drug delivery
US3760807A (en) * 1972-04-07 1973-09-25 C Neefe Method of reshaping the cornea to eliminate refractive errors
DE2308144A1 (de) * 1973-02-19 1974-08-22 Battelle Institut E V Kontakklinse
US3776230A (en) * 1973-04-18 1973-12-04 C Neefe Method of rapidly reshaping the cornea to eliminate refractive errors
US3831604A (en) * 1973-04-18 1974-08-27 C Neefe Method of reshaping the cornea
US3957049A (en) * 1973-10-09 1976-05-18 Neefe Charles W Rechargeable drug delivery method
DE2426757A1 (de) * 1974-06-01 1975-12-11 Norbert Armin Guenther Kontaktlinse
US4484922A (en) * 1981-06-25 1984-11-27 Rosenwald Peter L Occular device
US4571039A (en) * 1983-04-15 1986-02-18 Stanley Poler Eye-medicating contact-lens construction
US4540417A (en) * 1983-05-02 1985-09-10 Stanley Poler Eye-medicating haptic
US4592752A (en) * 1985-08-02 1986-06-03 Neefe Charles W Non-optical corneal drug delivery
SU1621921A1 (ru) * 1987-07-22 1991-01-23 Киргизский государственный медицинский институт Способ лечени прогрессирующей близорукости
US5270051A (en) * 1991-10-15 1993-12-14 Harris Donald H Enzyme-orthokeratology

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998010785A1 (fr) * 1996-09-13 1998-03-19 Advanced Medicine Research Institute Compositions ophtalmiques de facteurs neurotrophiques, remedes pour troubles fonctionnels du nerf optique et procede de traitement de tels troubles
JP2018016646A (ja) * 2003-12-19 2018-02-01 オシオ コーポレイション 眼科的状態の処置
JP2007514760A (ja) * 2003-12-19 2007-06-07 オシオ コーポレイション 眼科的状態の処置
US9931382B2 (en) 2003-12-19 2018-04-03 Osio Corporation Treatment of ophthalmic conditions
JP2011153153A (ja) * 2003-12-19 2011-08-11 Osio Corp 眼科的状態の処置
US9241980B2 (en) 2003-12-19 2016-01-26 Osio Corporation Treatment of ophthalmic conditions
JP2013078659A (ja) * 2003-12-19 2013-05-02 Osio Corp 眼科的状態の処置
US8877228B2 (en) 2003-12-19 2014-11-04 Osio Corporation Treatment of ophthalmic conditions
JP2015180354A (ja) * 2003-12-19 2015-10-15 オシオ コーポレイション 眼科的状態の処置
JP2017057219A (ja) * 2003-12-19 2017-03-23 オシオ コーポレイション 眼科的状態の処置
US9566317B2 (en) 2003-12-19 2017-02-14 Osio Corporation Treatment of ophthalmic conditions
WO2009090763A1 (ja) * 2008-01-16 2009-07-23 Tokuichiro Hasegawa 視力矯正冶具及び同冶具用の冷却流体注入具
JP2011516154A (ja) * 2008-04-04 2011-05-26 フォーサイト ラブズ， エルエルシー 疼痛管理および視力のための治療装置
JP2011167992A (ja) * 2010-02-21 2011-09-01 Seed Co Ltd 環状医療具の成形型及びこの成形型を用いて成形された環状医療具
JP2015508319A (ja) * 2012-01-27 2015-03-19 エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ （ウ・ペ・エフ・エル）Ｅｃｏｌｅ Ｐｏｌｙｔｅｃｈｎｉｑｕｅ Ｆｅｄｅｒａｌｅｄｅ Ｌａｕｓａｎｎｅ （Ｅｐｆｌ） 懸濁液中の細胞を移植するためのデバイス
US10969609B2 (en) 2012-08-10 2021-04-06 Osio Corporation Contact lens use in the treatment of an ophthalmologic condition
US10254564B2 (en) 2012-08-10 2019-04-09 Osio Corporation Contact lens use in the treatment of an ophthalmologic condition
JP2015524580A (ja) * 2012-08-10 2015-08-24 オシオ コーポレイション ディー／ビー／エー ヨリア ヘルス 眼科的状態の治療におけるコンタクトレンズ使用
US9086580B2 (en) 2012-08-10 2015-07-21 Osio Corporation Contact lens use in the treatment of an ophthalmologic condition
JP2016521377A (ja) * 2013-03-29 2016-07-21 ワンフォーカス テクノロジー， エルエルシー 流体モジュールを有するコンタクトレンズからの薬物送達
JP2015036080A (ja) * 2013-08-14 2015-02-23 石根 三井 矯正角膜クロスリンキング用コンタクトレンズ及び矯正角膜のクロスリンキング方法
US10564447B2 (en) 2013-11-20 2020-02-18 Iwane Mitsui Contact lens for corrected-cornea crosslinking, corrected-cornea crosslinking method, and ring-shaped contact lens
WO2015076215A1 (ja) * 2013-11-20 2015-05-28 石根 三井 矯正角膜クロスリンキング用コンタクトレンズ、矯正角膜のクロスリンキング方法及びリング状コンタクトレンズ
WO2016056575A1 (ja) * 2014-10-10 2016-04-14 石根 三井 矯正角膜クロスリンキング用コンタクトレンズ
JP2016077873A (ja) * 2014-10-10 2016-05-16 石根 三井 矯正角膜クロスリンキング用コンタクトレンズ
US9664926B2 (en) 2014-10-10 2017-05-30 Iwane Mitsui Contact lens for cornea-correction crosslinking
JP2016081028A (ja) * 2014-10-10 2016-05-16 石根 三井 リング状角膜矯正用コンタクトレンズ
JPWO2017111027A1 (ja) * 2015-12-22 2018-09-13 株式会社三井メディカルコマース 矯正角膜クロスリンキング用コンタクトレンズ及びその製造方法
CN108601673A (zh) * 2015-12-22 2018-09-28 三井医学贸易有限公司 矫正角膜胶原交联用隐形眼镜及其制造方法
US10722401B2 (en) 2015-12-22 2020-07-28 Mitsui Medical Commerce Co, Ltd. Contact lens for corrective corneal crosslinking and method for producing same
WO2017111027A1 (ja) * 2015-12-22 2017-06-29 石根 三井 矯正角膜クロスリンキング用コンタクトレンズ及びその製造方法
JP2019511493A (ja) * 2016-03-08 2019-04-25 ユニバーシティー オブ ユタ リサーチ ファウンデーションＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｕｔａｈ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 交差架橋剤、及び関連する方法
JP2021185154A (ja) * 2016-03-08 2021-12-09 ユニバーシティー オブ ユタ リサーチ ファウンデーションUniversity of Utah Research Foundation 交差架橋剤、及び関連する方法
JP2022544020A (ja) * 2019-07-24 2022-10-17 テウォン ファーム カンパニー リミテッド コンタクトレンズ、及びそれを製造するためのモールド

Also Published As

Publication number Publication date
CA2120709C (en) 2004-12-28
BR9206629A (pt) 1995-05-02
AU668526B2 (en) 1996-05-09
DE69232515D1 (de) 2002-05-02
CA2120709A1 (en) 1993-04-29
ES2173870T3 (es) 2002-11-01
WO1993007840A1 (en) 1993-04-29
ATE214904T1 (de) 2002-04-15
KR100271241B1 (ko) 2000-10-16
AU2877392A (en) 1993-05-21
US5626865A (en) 1997-05-06
EP0608341B1 (en) 2002-03-27
CZ285542B6 (cs) 1999-09-15
RU2137449C1 (ru) 1999-09-20
KR100256038B1 (ko) 2000-06-01
US5270051A (en) 1993-12-14
CZ90694A3 (en) 1994-11-16
EP0608341A1 (en) 1994-08-03
SG48971A1 (en) 1998-05-18
DE69232515T2 (de) 2003-08-28

Similar Documents

Publication Publication Date Title
JPH07500267A (ja) 酵素−角膜矯正法
US5788957A (en) Enzyme-orthokeratology
EP1061873B1 (en) Use of glyceraldehyde as corneal hardening agents
US9241980B2 (en) Treatment of ophthalmic conditions
US6923955B2 (en) Presbyopia treatment by lens alteration
US20020025311A1 (en) Presbyopia treatment by lens alteration
Peña-García et al. Keratoconus management guidelines
US20120057121A1 (en) Orthokeratology lens wear combined with chemical treatment to correct myopia, hyperopia or astigmatism
EP1173198B1 (en) Use of a determined hyaluronidase to eliminate corneal scars, opacification and haze
EP1159941A2 (en) Formulations for use in enzyme-orthokeratology
CN113633760A (zh) 转谷氨酰胺酶在抑制或延缓近视药物中的应用
MXPA00008785A (en) Use of corneal hardening agents in enzyme orthokeratology
AU2002243589B2 (en) Presbyopia treatment by lens alteration
AU2007202325B2 (en) Presbyopia treatment by lens alteration
HK1099232B (en) Treatment of ophthalmic conditions

Legal Events

Date Code Title Description
A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20060627